<DOC>
	<DOC>NCT00185263</DOC>
	<brief_summary>The purpose of this study is to determine whether a single intracoronary infusion of Ad5FGF-4 is effective in improving exercise capacity measured by exercise treadmill testing, angina functional class, patient symptoms, quality of life, and cardiovascular outcomes. To doses are to be studied, 2.87x10(8) and 2.87x10(9) viral particles, to evaluate the dose-response of Ad5FGF-4. Short-term and long-term safety of Ad5FGF-4 will also be evaluated.</brief_summary>
	<brief_title>Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina, Stable</mesh_term>
	<criteria>CCS class II IV, technically unsuitable for revascularization by CABG or PTCA able to exercise between 3 and 10 minutes on treadmill Unstable angina, CCS class 1 angina optimal candidates for revascularization</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>angina</keyword>
	<keyword>FGF-4</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>adenovector</keyword>
	<keyword>growth factor</keyword>
	<keyword>myocardial ischemia</keyword>
	<keyword>revascularization</keyword>
</DOC>